Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.3 USD | -0.92% | +1.73% | -11.15% |
02/05 | Jazz Pharmaceuticals Q1 Adjusted Earnings Decline, Revenue Rises; Reaffirms 2024 Outlook | MT |
01/05 | (JAZZ) JAZZ PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $18.15 - $19.35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.15% | 6.81B | |
+29.68% | 681B | |
+20.07% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.36% | 235B | |
+4.37% | 199B | |
-11.78% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Earnings Reaction History: Jazz Pharmaceuticals plc, 60.0% Follow-Through Indicator, 6.5% Sensitive